Manage Your Liver
Q:

I am infected with HCV, if I do not undergo antiviral treatment (due to the cost and side effects), is it possible for me to maintain normal liver function?

A:

Sometimes, people infected with HCV choose not to or cannot undergo treatment to eradicate the virus because of a number of reasons (e.g. price of treatment, side effects, condition of the liver, overall health condition, recurring infection, etc.) [1] When not using antiviral treatment, patients should aim at protecting their liver cells from damage and preserving liver function. [2]

 

For hepatitis C patients, maintaining normal liver function can greatly reduce the risk of cirrhosis and liver cancer. The liver can regenerate most of its own cells when they become damaged. However, if the injury is severe or long lasting, regeneration is incomplete, and the liver creates scar tissue. Scarring of the liver or fibrosis, may lead to cirrhosis. [3] And cirrhosis is the main cause for primary liver cancer. [4]

 

People infected with hepatitis virus may find it more difficult to maintain normal liver function than those who do not have the virus. However, there is little correlation between the severity of liver damage and HCV viral load. A high viral load does not indicate serious liver damage, similarly, a low viral count does not equal little liver injury. [5] Hence, maintaining normal liver function is possible even without eradication of the virus. In fact, this has already been proven in scientific research. [6]

 

People with HCV infection who are unable to undergo virus eradication treatment should focus on adopting lifestyle changes to reduce workload on the liver, avoiding harmful substances to the liver and enhancing immune function to fend off liver damage from the virus.

 

For more tips please read: How can I reduce workload on the liver and increase immune function of the liver?

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us